Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lydia M. Mexas"'
Autor:
E Danielle Dean, Lydia M Mexas, Natalie L Cápiro, Jeanne E McKeon, Mahlon R DeLong, Kurt D Pennell, Jonathan A Doorn, Vin Tangpricha, Gary W Miller, Marian L Evatt
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e39227 (2012)
Recent clinical evidence supports a link between 25-hydroxyvitamin D insufficiency (serum 25-hydroxyvitamin D [25(OH)D] levels
Externí odkaz:
https://doaj.org/article/4de7426d10e342cea54c7441f927f4d9
Autor:
Jonathan A. Doorn, David G. Anderson, Virginia R. Florang, Lydia M. Mexas, Erin M. G. Allen, Yunden Jinsmaa, Laurie L. Eckert, Jennifer N. Rees
Publikováno v:
Chemico-Biological Interactions. 192:118-121
Dopamine (DA) undergoes monoamine oxidase catalyzed oxidative deamination to 3,4-dihydroxyphenylacetaldehyde (DOPAL), which is metabolized primarily to 3,4-dihydroxyphenylacetic acid (DOPAC) via aldehyde dehydrogenase (ALDH). Previous studies demonst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2772e4362949a32c504e07c88eb2f773
https://doi.org/10.1016/j.cbi.2011.01.006
https://doi.org/10.1016/j.cbi.2011.01.006
Publikováno v:
Neurotoxicology. 32(4)
Parkinson's disease (PD) is a neurodegenerative disorder marked by the selective loss of dopaminergic neurons, leading to a decrease of the neurotransmitter dopamine (DA). DA is metabolized by monoamine oxidase to 3,4-dihydroxyphenyacetaldehyde (DOPA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bd303dd5026ba18f4e0494aa1765245
https://pubmed.ncbi.nlm.nih.gov/21514317
https://pubmed.ncbi.nlm.nih.gov/21514317